<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00762970</url>
  </required_header>
  <id_info>
    <org_study_id>CR-1561AB</org_study_id>
    <nct_id>NCT00762970</nct_id>
  </id_info>
  <brief_title>Controlling Myopia Progression With Soft Contact Lenses</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johnson &amp; Johnson Vision Care, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johnson &amp; Johnson Vision Care, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate whether novel soft contact lens optical designs can slow myopia
      progression.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a prospective, randomized, single blind, bilateral dispensing study
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Spherical Equivalent Refraction</measure>
    <time_frame>Baseline and every 6 months post-baseline for 2 years</time_frame>
    <description>Spherical equivalent refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor (WAM-5500) and descriptively summarized for each follow-up. Higher spherical refraction indicates progression in Myopia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Axial Length (Axial Elongation)</measure>
    <time_frame>Baseline and every 6 months post-baseline for 2 years</time_frame>
    <description>Axial length was measured with the IOLMaster at baseline and every 6 months post-baseline for 2 years. Axial length was descriptively summarized for each follow-up.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>Test Lens 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational soft contact lenses worn daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Lens 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Investigational soft contact lenses worn daily.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control lens</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Spectacle lenses worn daily.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test Lens 1</intervention_name>
    <description>Investigational soft contact lens with asperic optical design to control myopia progression.</description>
    <arm_group_label>Test Lens 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Test Lens 2</intervention_name>
    <description>Investigational soft contact lens with asperic optical design to control myopia progression.</description>
    <arm_group_label>Test Lens 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Control Lens</intervention_name>
    <description>Spectacle Lenses.</description>
    <arm_group_label>Control lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Myopic subjects between 8 and 12 years of age.

          2. The subject best sphere contact lens correction must lie between -0.75D (best of the
             two eyes) and -5.00D (worst of the two eyes)

          3. Astigmatism must be less than or equal to 1.00D

          4. 1.00D or less difference in spherical equivalent between the two eyes

          5. The subject must have a best-corrected visual acuity of 0.8+2 (20/25+2) and spherical
             equivalent refraction visual acuity of 0.820/25) or better in both eyes

          6. The subject must have at least 8D of accommodation

          7. The subject and subject's parent or legal guardian must read and sign the STAEMENT OF
             INFORMED CONSENT

          8. The subject must appear able and willing to adhere to the instructions set forth in
             this clinical protocol.

        Exclusion Criteria:

          1. Any ocular or systemic allergies or diseases that may interfere with contact lens
             wear.

          2. Systemic disease or autoimmune disease or use of medication (e.g. antihistamine),
             which may interfere with lens wear.

          3. Clinically significant (grade 3 or 4)corneal edema, corneal vascularization, corneal
             staining, or any other abnormality of the cornea, which may contraindicate contact
             lens wear.

          4. Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection that
             might interfere with contact lens wear.

          5. Any ocular infection.

          6. Any corneal distortion resulting from previous hard or rigid gas permeable contact
             lens wear.

          7. Any infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease
             (e.g. HIV)

          8. Diabetes

          9. Anisometropia of greater than 1.00D

         10. Astigmatism of greater than 1.00D in either eye

         11. Eye injury or surgery within eight weeks immediately prior to enrollment for this
             study.

         12. Pervious refractive surgery, rigi contact lens wear, orthokeratology, keratconus or
             other corneal irregularity in either eye.

         13. Strabismus in either eye

         14. Pupil orr lid abnormality or infection in either eye

         15. Central corneal scar in either eye

         16. Aphakia in either eye

         17. Contraindications to contact lens wear such as dry eye or history of prior
             unsuccessful contact lens wear.

         18. History of participation in prior clinical trials aimed to control myopia progression

         19. Surgically altered eyes, ocular infection of any type, ocular inflammation

         20. Subject has anterior chamber angle grade 2 or narrower
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xu Cheng, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Clinical Scientist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Tianjin Eye Hospital</name>
      <address>
        <city>Tianjin</city>
        <zip>300020</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2008</study_first_submitted>
  <study_first_submitted_qc>September 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 30, 2008</study_first_posted>
  <results_first_submitted>July 1, 2015</results_first_submitted>
  <results_first_submitted_qc>July 1, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 29, 2015</results_first_posted>
  <last_update_submitted>May 4, 2016</last_update_submitted>
  <last_update_submitted_qc>May 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myopia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>Of those 150 screened subjects, 3 were not eligible to participate in the study and 10 were not randomized to the study lens groups. 115 subjects completed all study visits without a major protocol deviation.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Test Lens 1</title>
          <description>Investigational soft contact lenses worn daily.</description>
        </group>
        <group group_id="P2">
          <title>Test Lens 2</title>
          <description>Investigational soft contact lenses worn daily.</description>
        </group>
        <group group_id="P3">
          <title>Control Lens</title>
          <description>Control spectacle lenses worn daily.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="44"/>
                <participants group_id="P3" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="35"/>
                <participants group_id="P3" count="46"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="4"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Difficulty of handling lens</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Baseline summary was conducted on all subjects who randomized in the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Test Lens 1</title>
          <description>Investigational soft contact lens worn daily.</description>
        </group>
        <group group_id="B2">
          <title>Test Lens 2</title>
          <description>Investigational soft contact lens worn daily.</description>
        </group>
        <group group_id="B3">
          <title>Control Lens</title>
          <description>Spectacle lenses worn daily.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="46"/>
            <count group_id="B2" value="44"/>
            <count group_id="B3" value="47"/>
            <count group_id="B4" value="137"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="47"/>
                    <measurement group_id="B4" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9.8" spread="1.1"/>
                    <measurement group_id="B2" value="9.8" spread="1.2"/>
                    <measurement group_id="B3" value="9.7" spread="1.2"/>
                    <measurement group_id="B4" value="9.8" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="26"/>
                    <measurement group_id="B4" value="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="21"/>
                    <measurement group_id="B4" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>China</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="47"/>
                    <measurement group_id="B4" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Spherical Equivalent Refraction</title>
        <description>Spherical equivalent refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor (WAM-5500) and descriptively summarized for each follow-up. Higher spherical refraction indicates progression in Myopia.</description>
        <time_frame>Baseline and every 6 months post-baseline for 2 years</time_frame>
        <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
        <group_list>
          <group group_id="O1">
            <title>Test Lens 1</title>
            <description>Investigational soft contact lenses worn daily.</description>
          </group>
          <group group_id="O2">
            <title>Test Lens 2</title>
            <description>Investigational soft contact lenses worn daily.</description>
          </group>
          <group group_id="O3">
            <title>Control Lens</title>
            <description>Spectacle lenses worn daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Spherical Equivalent Refraction</title>
          <description>Spherical equivalent refraction was computed from the sphero-cylindrical refraction measured with an open-field auto refractor (WAM-5500) and descriptively summarized for each follow-up. Higher spherical refraction indicates progression in Myopia.</description>
          <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
          <units>diopter (D)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="37"/>
                <count group_id="O3" value="46"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from baseline 6 months; N=68, N=74, N=92</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.326" spread="0.6678"/>
                    <measurement group_id="O2" value="-0.460" spread="0.3938"/>
                    <measurement group_id="O3" value="-0.430" spread="0.3942"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 12 months; N=70, N=72, N=90</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.898" spread="0.4695"/>
                    <measurement group_id="O2" value="-0.859" spread="0.4955"/>
                    <measurement group_id="O3" value="-0.905" spread="0.5918"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 18 months; N=70, N=72, N=88</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.222" spread="0.8501"/>
                    <measurement group_id="O2" value="-1.185" spread="0.6550"/>
                    <measurement group_id="O3" value="-1.336" spread="0.7361"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 24 months; N=48, N=52, N=68</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.506" spread="0.9346"/>
                    <measurement group_id="O2" value="-1.376" spread="0.5891"/>
                    <measurement group_id="O3" value="-1.809" spread="0.9485"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Axial Length (Axial Elongation)</title>
        <description>Axial length was measured with the IOLMaster at baseline and every 6 months post-baseline for 2 years. Axial length was descriptively summarized for each follow-up.</description>
        <time_frame>Baseline and every 6 months post-baseline for 2 years</time_frame>
        <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
        <group_list>
          <group group_id="O1">
            <title>Test Lens 1</title>
            <description>Investigational soft contact lenses worn daily.</description>
          </group>
          <group group_id="O2">
            <title>Test Lens 2</title>
            <description>Investigational soft contact lenses worn daily.</description>
          </group>
          <group group_id="O3">
            <title>Control Lens</title>
            <description>Spectacle lenses worn daily.</description>
          </group>
        </group_list>
        <measure>
          <title>Axial Length (Axial Elongation)</title>
          <description>Axial length was measured with the IOLMaster at baseline and every 6 months post-baseline for 2 years. Axial length was descriptively summarized for each follow-up.</description>
          <population>Analysis was conducted on all randomized subjects who have at least one data point.</population>
          <units>millimeter (mm)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <units_analyzed>Participants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="37"/>
                <count group_id="O3" value="46"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>eyes</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="70"/>
                <count group_id="O2" value="74"/>
                <count group_id="O3" value="92"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from baseline 6 months; N=68, N=74, N=92</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.214" spread="0.1020"/>
                    <measurement group_id="O2" value="0.198" spread="0.1128"/>
                    <measurement group_id="O3" value="0.263" spread="0.1766"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 12 months; N=70, N=72, N=90</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.401" spread="0.1816"/>
                    <measurement group_id="O2" value="0.382" spread="0.1974"/>
                    <measurement group_id="O3" value="0.458" spread="0.2323"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 18 months; N=70,N=72, N=88</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.564" spread="0.2371"/>
                    <measurement group_id="O2" value="0.522" spread="0.2643"/>
                    <measurement group_id="O3" value="0.622" spread="0.2805"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from baseline 24 months; N=48, N=52, N=68</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.660" spread="0.2355"/>
                    <measurement group_id="O2" value="0.529" spread="0.2378"/>
                    <measurement group_id="O3" value="0.749" spread="0.3203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Test Lens 1</title>
          <description>Investigational soft contact lenses worn daily.</description>
        </group>
        <group group_id="E2">
          <title>Test Lens 2</title>
          <description>Investigational soft contact lenses worn daily.</description>
        </group>
        <group group_id="E3">
          <title>Control Lens</title>
          <description>Control spectacle lenses worn daily.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="46"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>XU CHENG, PRINCIPAL CLINICAL SCIENTIST</name_or_title>
      <organization>Vistakon USA</organization>
      <phone>1 904 443-1245</phone>
      <email>xcheng6@its.jnj.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

